Recent Articles from Investor Brand Network

Datavault AI (NASDAQ: DVLT) announced the live deployment of its ADIO(R) athlete engagement platform at the NFL Draft, delivering real-world validation of the technology in a high-profile, high-demand environment through its partnership with the NFL Alumni Health initiative. The company said the activation is generating strong engagement among draftees, alumni and league stakeholders, reinforcing the platform’s scalability and commercial viability, while supporting its push toward the launch of DataVault NILX, a name, image and likeness monetization platform targeting a rapidly growing multi-billion-dollar market opportunity across collegiate NIL and global sports sponsorship.

Wearable Devices (NASDAQ: WLDS) announced the United States Patent and Trademark Office has issued a Notice of Allowance for a continuation patent within its “Gesture and Voice-Controlled Interface Device” family, covering authentication technologies that combine gesture recognition with unique biological signals. The allowed claims describe a system integrating gesture and biopotential sensors to analyze neural signals and create personalized gesture signatures for highly accurate user verification, enabling applications such as secure payments, access control and user authentication. The company said the development strengthens its intellectual property portfolio and supports broader adoption of its AI-powered touchless interface technology across AR/VR, enterprise and smart environments.

Telomir Pharmaceuticals (NASDAQ: TELO) announced the closing of its acquisition of TELI Pharmaceuticals, Inc., establishing the company as the sole global rights holder of Telomir-1 (Telomir-Zn) and eliminating prior geographic fragmentation of the asset. The transaction, approved by shareholders in March, includes $1.0 million in funding at closing and up to an additional $4.0 million in milestone-based contributions tied to clinical development progress.

American Fusion (OTC: AMFN) was featured in an AINewsWire editorial titled “Energy Constraints Emerging as Critical Factor in Sustaining AI Expansion,” highlighting the growing energy demands driven by increasingly complex artificial intelligence systems. The piece underscores how rising electricity consumption from data centers is straining infrastructure and emerging as a key limiting factor in AI growth, while positioning American Fusion at the intersection of advanced energy development and next-generation infrastructure through its focus on aneutronic fusion and scalable energy solutions designed to support AI-driven workloads.

On Wednesday, lawmakers in Turkey passed legislation that bans individuals who are less than 15 years of age from accessing social media. The bill now awaits the signature of the country’s president before it can become law.

Electric vehicle sales across Europe saw a strong rise in March 2026, showing how quickly people are changing the way they travel. New data shows that electric car sales increased by 51% compared to the same time last year.

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) and may include paid advertising.

The ongoing transition from fossil fuels to renewables is currently facing a challenge that is simultaneously ironic and pressing as the climate instability that renewables are built to address is now degrading their performance. Extreme heat reduces solar output, volatile precipitation undermines hydropower, and intensifying storms are forcing wind turbines into protective shutdowns. The global warming that makes the transition necessary is making it harder to execute.

Cryptocurrency markets are coming under fresh strain after hackers believed to be linked to North Korea executed two major breaches, draining more than $500 million in just over two weeks. The incidents targeting Kelp DAO and Drift point to a more organized pattern aimed at structural flaws within decentralized finance rather than isolated software bugs.

Battery electric vehicles are expanding rapidly across global markets as governments and carmakers push toward cleaner transport. However, beneath this progress lies a growing challenge that threatens long-term production goals. The issue is not a lack of nickel in general, but a shortage of battery-grade nickel that is essential for EV batteries.

Lantern Pharma (NASDAQ: LTRN) announced it will host its first live, public demonstration of its withZeta.ai multi-agentic AI co-scientist platform on April 30, 2026, with two sessions scheduled to accommodate global audiences. The event will feature a real-time, interactive demonstration led by CEO Panna Sharma, showcasing the platform’s ability to execute complex oncology research workflows by integrating clinical, molecular and scientific datasets. Lantern said the platform is designed to accelerate drug discovery timelines, particularly in rare cancers, while supporting a scalable, subscription-based commercial model.

OptimumBank Holdings (NYSE American: OPHC) reported net income of $4.7 million, or $0.39 per basic share, for the first quarter of 2026, compared to $3.9 million in the prior-year period, driven by higher net interest income and modest gains in noninterest income. The company also posted strong balance sheet expansion, with total deposits rising 17.3% to $1.09 billion and gross loans increasing 13.8% to $1.09 billion during the quarter, reflecting continued momentum across its relationship-based banking model.

So far this year, the Bank of Russia has divested gold amounting to about 22 tons in a bid to fund the deficit in its budget. The budget shortfall amounted to approximately $61.3 billion by March’s end due to dwindling revenues from oil and gas.

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

Nightfood Holdings (OTCQB: NGTF) announced the launch of a live pilot deployment of its autonomous robots, BIM-E and TIM-E, at the IOA Championship presented by Morongo Casino Resort and Spa, taking place April 24–26, 2026, at Morongo Golf Club at Tukwet Canyon in California. The deployment marks a key step in the company’s commercialization strategy, with the robots providing beverage service, waste management and delivery in a high-traffic event setting, while demonstrating scalability across outdoor hospitality environments. Following the event, the systems are expected to remain onsite for ongoing clubhouse operations, supporting continued validation as Nightfood advances production and scaling efforts in collaboration with Foxconn and NUWA Robotics.

This article has been disseminated on behalf of SureNano Science Ltd. and may include paid advertising.

Oncotelic Therapeutics (OTCQB: OTLC) is featured in a NetworkNewsAudio Audio Press Release titled “When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech,” which highlights how late-stage drug development assets increasingly drive valuation in the biopharma sector. The editorial, supported by analysis from McKinsey & Company, notes that companies tend to realize the majority of value creation as products approach commercialization, reflecting reduced risk and clearer revenue visibility, a trend directly relevant to Oncotelic’s oncology-focused pipeline and strategic development approach.

Scinai Immunotherapeutics (NASDAQ: SCNI) announced it has entered into a securities purchase agreement with institutional and accredited investors for the sale of 5,208,333 ADSs at $0.48 per ADS, along with accompanying Series A and Series B warrants, and separately executed a warrant inducement agreement with an existing investor. The combined transactions are expected to generate approximately $2.61 million in gross proceeds, with closing anticipated on or about April 27, 2026, subject to customary conditions. The company said proceeds will support expansion of its CDMO platform, advancement of customer programs and continued investment in its immunotherapy pipeline.

Oncotelic Therapeutics (OTCQB: OTLC) provided a corporate update emphasizing its partnership-driven strategy to advance its oncology and rare disease pipeline and enhance shareholder value. The company cited its joint venture with GMP Biotechnology, which contributed to a $249.0 million increase in its balance sheet based on an independent third-party valuation, and said it is pursuing additional collaborations to support development and commercialization efforts. Management noted the approach is designed to advance multiple drug candidates in parallel while maintaining capital efficiency and unlocking the value of its intellectual property portfolio.

Strawberry Fields REIT (NYSE AMERICAN: STRW) announced it will report its first quarter 2026 financial results before the market opens on May 8, 2026, and will host a conference call and webcast at 12:00 p.m. Eastern Time the same day to discuss the results. Investors are invited to pre-register for the call to receive dial-in details, while a live listen-only webcast and a replay will be available via the company’s website.

This article has been disseminated on behalf of Planet Ventures Inc. and may include paid advertising.

Strawberry Fields REIT (NYSE AMERICAN: STRW) announced it will report its first quarter 2026 financial results before the market opens on May 8, 2026, and will host a conference call and webcast at 12:00 p.m. Eastern Time the same day to discuss the results. Investors are invited to pre-register for the call to receive dial-in details, while a live listen-only webcast and a replay will be available via the company’s website.

Last December, President Trump signed Executive Order 14067, titled “Increasing Medical Marijuana and Cannabidiol Research.” The directive calls for marijuana to be reclassified from Schedule 1 to 3 under the Controlled Substances Act (CSA), a move that could reshape the financial landscape for cannabis businesses.

Forward Industries (NASDAQ: FWDI) was featured in a recent article that discussed its positioning as an easy way for investors to take advantage of current market prices and ride the long-term crypto wave. The publication reads, “Solana (SOL) is seen as one of the most performant cryptocurrencies, due to high transaction volumes, fast speeds, and very low transaction costs. In turn, this idea also applies to Forward Industries, which is a large-scale Solana treasury company and the biggest publicly traded Solana treasury platform, with over 6.9 million SOL in total holdings. It also has a validator infrastructure that has generated between 6.5% and 7.2% gross annual percentage yield before fees, which outperforms many peer validators. Forward Industries also actively participates in the Solana ecosystem, by using assets for on-chain activities like staking, lending, and participating in decentralized finance (‘DeFi’).”

HeartBeam (NASDAQ: BEAT) was featured in a recent article that discussed its collaboration with Mount Sinai aimed at advancing artificial intelligence-driven electrocardiogram technology. The publication indicates that the move, “highlights HeartBeam’s growing focus on artificial intelligence (‘AI’)-enabled analysis and reinforces the relevance of its technology as healthcare increasingly shifts toward data-driven, remote monitoring solutions. The announcement outlines a strategic collaboration between HeartBeam and Mount Sinai to develop and validate high value, AI-based ECG algorithms that can be deployed broadly across HeartBeam’s platform. These AI models may include patient-relevant wellness insights, condition-focused assessments, and applications for chronic condition management.”

ACP Holdings Acquisition announced the closing of its initial public offering of 20 million units priced at $10.00 each, generating gross proceeds of $200 million, alongside a concurrent private placement of 485,000 units that brought total funds placed in trust to approximately $201 million. The company, a blank check firm focused on pursuing a business combination with companies valued at $750 million or more, began trading on Nasdaq under “ACGCU,” with underlying shares and warrants expected to trade separately as “ACGC” and “ACGCW.” Roth Capital Partners acted as the sole book-running manager for the offering.

Versus Systems (NASDAQ: VS) is a technology company focused on enhancing the way audiences interact with content across digital and live environments. “The company’s platform enables brands, teams, and content creators to integrate interactive elements directly into their experiences, allowing users to participate in games and earn real-world rewards while engaging with media,” reads an article discussing the company. “By combining gameplay mechanics with promotional functionality, Versus provides a framework for turning passive audiences into active participants. Its patented earned-rewards system is designed to operate across mobile, web, broadcast, and in-venue formats, supporting both audience participation and measurable brand interaction without requiring significant development resources.”

Oncotelic Therapeutics (OTCQB: OTLC) announced its inclusion in a BioMedWire editorial examining how advancing drug pipelines are reshaping biotech valuations, as scientific progress is increasingly recognized as a measurable financial asset under evolving accounting frameworks. The piece highlights Oncotelic’s position at the intersection of oncology and AI-driven drug development, noting its diversified pipeline and strategic holdings, including a 45% stake in GMP Bio, as examples of how innovation and clinical advancement are being reflected in tangible enterprise value.

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

Micropolis AI Robotics (NYSE American: MCRP) announced it has signed an engineering and manufacturing agreement with DP World to support the development and deployment of a container ascending system aimed at improving efficiency and safety in logistics operations. The collaboration marks an expansion into maritime and industrial automation, positioning Micropolis alongside global infrastructure and technology leaders advancing AI-driven systems and next-generation logistics solutions, while reinforcing its role in high-growth automation markets.

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), the only dual-platform quantum computing company providing both annealing and gate-model systems, software and services, today announced it will release its financial results for the first quarter of fiscal year 2026 ended March 31, 2026 on Tuesday, May 12, 2026 before market open. The press release will be available on the D-Wave Investor Relations website: https://ir.dwavequantum.com .

Gold continues to demonstrate its resilience as a safe-haven asset, even amid volatility linked to the Iran conflict and shifting market sentiment. Analysts note that while geopolitical tensions initially triggered declines in gold prices , particularly in early March following U.S. military actions, these movements were influenced as much by speculative trading as by fundamentals.

Automation is becoming a structural feature of renewable energy development, with robots now performing tasks across every phase of a project. Advances in artificial intelligence and purpose-built hardware have expanded what machines can handle on a construction or maintenance site. Energy companies can now delegate hazardous or time-intensive tasks that previously exceeded the capacity of human teams alone.

Germany expects to have close to eight million electric vehicles on its roads by 2030. The projection is built from sales forecasts submitted by the country’s major automakers. The estimate was produced by NOW GmbH, a government-affiliated body working with the transport ministry.

Crypto asset investment products recorded their most significant weekly inflows in several months, signaling a renewed wave of investor confidence. Data from CoinShares shows that $1.4 billion entered crypto funds over the last week, extending a three-week streak of positive flows and pushing total assets under management to $155 billion (a 0.91% increase).

Researchers have developed a urine test that can screen for tumor DNA and detect whether a patient has residual bladder cancer after they have undergone surgery to remove the tumor. This test may also detect whether immunotherapy treatment administered after surgery has been effective or residual bladder cancer remains.

On Tuesday, a federal judge issued a temporary injunction blocking the implementation of a number of actions by the federal government that plaintiffs said impeded the development of several solar and wind energy projects around the country.

Tinder is introducing a new identity check that relies on eye-scanning technology, part of a broader effort to address growing concerns about AI and fake online personas. The dating platform, alongside platforms such as Zoom, plans to allow users to verify themselves by scanning their irises .

ParaZero Technologies (NASDAQ: PRZO) announced it has signed a reseller agreement with Romania-based New Akord Security to market its DefendAir counter-drone system and provide training and local support, expanding its footprint across Europe and NATO-aligned markets. The agreement includes an initial demo kit purchase and planned live demonstration for Romanian defense officials at the BSDA exhibition in Bucharest, as the company builds momentum for its non-kinetic drone interception technology designed to protect military and civilian infrastructure.

American Fusion (OTC: AMFN) is emerging as a key player at the intersection of artificial intelligence and energy infrastructure, focusing on scalable aneutronic fusion solutions designed to meet surging electricity demand from data centers and AI workloads. As global power consumption accelerates, the company operates alongside established energy and technology leaders including NextEra Energy Inc. (NYSE: NEE), Duke Energy Corporation (NYSE: DUK), GE Vernova (NYSE: GEV) and Tesla Inc. (NASDAQ: TSLA), all working to modernize grid capacity and expand energy access, highlighting a broader industry shift toward advanced, reliable power systems capable of supporting the next generation of digital infrastructure.

Onshore basins of genuine scale that remain undrilled are increasingly rare. Most of the world’s major hydrocarbon-producing regions have been systematically tested over the past half-century, leaving frontier opportunities concentrated in geographies with challenging logistics, complex permitting, or historically limiting macroeconomic conditions.

This NewsBreak has been disseminated on behalf of Helus Pharma and may include paid advertising.

This article has been disseminated on behalf of Search Minerals Inc. and may include paid advertising.

Tonix Pharmaceuticals (NASDAQ: TNXP) announced new preclinical data from its immuno-oncology portfolio, including TNX-1700 and TNX-4700, presented through one oral and two poster sessions at the American Association for Cancer Research Annual Meeting 2026 in San Diego. The company reported findings supporting TNX-1700’s potential in reducing inflammation and tumor progression in gastric cancer models and demonstrating favorable pharmacokinetics, while TNX-4700 showed promising in vitro activity targeting BTLA, underscoring its potential as a cancer immunotherapy candidate alone or in combination with other checkpoint inhibitors.

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

Silo Pharma (NASDAQ: SILO) announced a strategic expansion into artificial intelligence as a second line of business following its acquisition of assets from Qwikagents.ai, a platform designed to deploy autonomous AI agents for tasks including research, content generation, scheduling and workflow automation. The company said the move positions it to capitalize on a rapidly growing AI agent market projected to reach $47 billion to $53 billion by 2030, while it continues advancing its SPC-15 PTSD program toward an investigational new drug application submission and Phase 1 clinical trials, underscoring a dual focus on biopharmaceutical development and emerging AI-driven revenue opportunities.

This article has been disseminated on behalf of Canamera Energy Metals Corp. and may include paid advertising.

AINewsWire Editorial Coverage : Artificial intelligence is no longer confined to software innovation; it is increasingly becoming an energy-intensive phenomenon. As AI systems grow in size and sophistication, the computational requirements needed to train and run them are triggering a sharp rise in electricity consumption, one that is beginning to strain existing infrastructure. Data centers, once considered purely digital enablers, are now among the most power-demanding assets in the global economy. This evolution is prompting governments, utilities and private enterprises alike to reassess a critical constraint: the limiting factor in AI’s expansion may not be computing power but energy availability. Within this shifting landscape, American Fusion(TM) Inc. (OTC: AMFN) ( Profile ) is positioning itself at the crossroads of advanced energy development and future infrastructure. By focusing on aneutronic fusion and the supporting supply chain, the company aims to develop scalable, efficient energy systems tailored to the needs of AI-driven workloads. Its strategy reflects a broader industry transition from theoretical exploration toward deployable energy solutions capable of sustaining long-term infrastructure demands. American Fusion operates alongside major players at the intersection of AI, energy demand and infrastructure, including NextEra Energy Inc. (NYSE: NEE), Duke Energy Corporation (NYSE: DUK), GE Vernova (NYSE: GEV) and…

This article has been disseminated on behalf of Energy Fuels Inc. and may include paid advertising.

According to Dr. Sanjay Gupta, his long-running documentary series “Weed” has grown far beyond its original scope, evolving into an ongoing examination of cannabis, medicine, and patient experience.

American Fusion (OTC: AMFN) announced its inclusion in an editorial published by AINewsWire, highlighting the growing strain AI-driven computing is placing on global energy infrastructure. The feature underscores the company’s positioning in aneutronic fusion and advanced energy systems aimed at supporting the rising power demands of hyperscale data centers and next-generation AI workloads.

American Fusion (OTC: AMFN) reported continued progress in building its intellectual property portfolio around its Texatron(TM) fusion platform, with approximately 280 patent filings in progress and plans to pursue an additional 300 filings covering reactor design, plasma behavior, and system integration. The company also highlighted ongoing regulatory preparations, including its upcoming Q1 2026 Form 10-Q, a potential Frankfurt Stock Exchange dual listing, and continued defense in Delaware litigation, as it positions its technology for commercialization, partnerships, and expanding energy market opportunities.

This article has been disseminated on behalf of Element 29 Resources Inc. and may include paid advertising.

Perpetuals.com (NASDAQ: PDC) announced the expansion of its BayesShield AI technology into healthcare with the launch of BayesShield Clinical, designed to identify physicians with the strongest diagnostic accuracy across specific case types. The platform applies the company’s statistical methodology, originally developed for financial markets, to reduce bias and improve clinical decision-making, with initial deployment supported through a partnership with the European Institute of Management to oversee pilot programs and academic validation.

NRx Pharmaceuticals (NASDAQ: NRXP) announced it received a positive Discipline Review Letter from the FDA Office of Generic Drugs covering quality-related aspects of its ketamine ANDA, with only minor administrative updates requested. The company also reported a supportive meeting with FDA leadership aligned with federal priorities to accelerate treatments for severe mental illness, reinforcing expectations for potential approval of its preservative-free ketamine product in summer 2026.

Nutriband (NASDAQ: NTRB) announced that CEO and Co-Founder Gareth Sheridan appeared on the Jack Neel Podcast to discuss the opioid crisis and the company’s AVERSA(TM) abuse-deterrent transdermal technology. The episode outlines how AVERSA(TM) is designed to reduce misuse, diversion, and accidental exposure of high-risk drugs such as fentanyl, while maintaining patient access, and is supported by a broad global patent portfolio.

This article has been disseminated on behalf of Trilogy Metals Inc. and may include paid advertising.

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) (FSE: P6U) and may include paid advertising.

SKYX Platforms (NASDAQ: SKYX) announced an agreement with OTT Heritage Hospitality to deploy and market its smart home and building technologies across European hotel chains and real estate developments. The partnership is expected to support large-scale adoption of SKYX’s technologies across hundreds of hotels and buildings, targeting deployment of hundreds of thousands of units while leveraging time and cost efficiencies of up to 90% for renovations and new builds, as part of the company’s broader global expansion strategy.

Datavault AI (NASDAQ: DVLT) announced the issuance of U.S. Patent No. 12,596,819 along with Notices of Allowance for two additional patent applications, strengthening its position in AI-driven data monetization, tokenization, and digital asset infrastructure. The expanded intellectual property portfolio supports platforms spanning data valuation, virtual asset funding, and automated tax solutions for digital assets, as the company advances commercialization efforts across multiple sectors and targets continued growth in emerging data and real-world asset markets.

BluSky AI (OTCID: BSAI), announced that CEO Trent D’Ambrosio will present at the AI & Tech Virtual Investor Conference hosted by VirtualInvestorConferences.com on April 23, 2026, at 1:30 p.m. ET. The live, interactive event will include real-time Q&A with investors, with additional availability for one-on-one meetings on April 23, 24, 27, and 28, and an archived webcast accessible following the presentation.

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.

Disseminated on behalf of CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) and may include paid advertising.

DitGold (CRYPTO: DITAU) was featured in a BiconomyCom Talks interview discussing its blockchain-based approach to treating data as a core economic asset through decentralized verification, tokenization, and monetization. Built on the Ethereum network, the project’s DitAu token supports governance, staking, and access to data-driven tools, as the company advances a phased roadmap aimed at enabling transparent, community-driven data ownership and infrastructure.

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

Oncotelic Therapeutics (OTCQB: OTLC) is emerging as a key example of how scientific progress is increasingly being reflected as measurable financial value across the biotechnology sector, supported by evolving fair-value accounting practices under U.S. GAAP. Operating at the intersection of oncology and AI-driven drug development, the company highlights this shift through its diversified pipeline and strategic holdings, including a 45% stake in GMP Bio valued at over $1 billion, alongside peers such as Autolus Therapeutics plc (NASDAQ: AUTL), Wave Life Sciences Ltd. (NASDAQ: WVE), IO Biotech Inc. (OTC: IOBTQ), and Roche Holding AG (OTC: RHHBY), as the industry transitions toward valuing clinical progress as an asset class.

Nightfood Holdings (OTCQB: NGTF) provided a corporate update outlining continued momentum through its TechForce Robotics subsidiary, including expansion of its U.S. footprint with a focus on East Coast distribution partnerships and ongoing discussions to enter select international markets. The company reported increasing demand for its AI-enhanced robotics solutions, with accelerated deployments, scaling production capacity, and infrastructure enhancements supporting its strategy for long-term growth in hospitality and service sectors.

The United Nations World Food Program (WFP) has introduced a new artificial intelligence program designed to track and monitor hunger risks across the world. The platform, known as HungerMap Live, is expected to change how governments and humanitarian organizations respond to food crises by offering early warnings and real-time data.

A personalized mRNA vaccine has shown signs of meaningfully extending survival in pancreatic cancer patients . Six-year results from a small but closely tracked clinical trial support that conclusion. The findings are being presented at a major oncology conference in San Diego.

AINewsWire Editorial Coverage : Satellite positioning has long served as the invisible backbone of military operations, underpinning everything from guided munitions to autonomous drone navigation, but that confidence is now fracturing. Across active combat theatres, navigation signals are being systematically jammed, spoofed and degraded at scale, turning one of warfare’s most relied-upon tools into one of its most exploitable vulnerabilities. Drones lose orientation, missions fail mid-flight, and entire system architectures collapse in electronically hostile conditions, prompting defense establishments worldwide to urgently seek alternatives capable of signal-free, satellite-independent operation. Into that gap, SPARC AI Inc. (OTC: SPAIF) ( Profile ) has introduced its software-based Overwatch platform, which enables unmanned systems to navigate and acquire targets in GPS-denied environments without any hardware modifications, a faster-to-deploy, more scalable alternative to the hardware-intensive solutions that currently dominate the sector. The company is part of a cohort of innovators, including Draganfly Inc. (NASDAQ: DPRO), AeroVironment Inc . (NASDAQ: AVAV), Kratos Defense & Security Solutions (NASDAQ: KTOS) and Red Cat Holdings Inc. (NASDAQ: RCAT), all operating where drone technology, artificial intelligence and defense capability intersect with a shared emphasis on autonomous and…

BioMedWire Editorial Coverage: The biotechnology industry is experiencing a subtle yet meaningful transformation that is redefining how value is interpreted within a sector long associated with extended development cycles and inherent uncertainty. As therapeutic candidates advance toward commercialization, scientific achievement is no longer viewed purely as an expense tied to research and development but rather as something that can be quantified as a financial asset. This transition is supported by fair-value accounting principles under U.S. GAAP, which enable life sciences companies to incorporate clinical progress, probability of success and expected commercialization timelines into measurable balance sheet value. Companies at the forefront of this shift, including Oncotelic Therapeutics Inc. (OTCQB: OTLC) ( Profile ), are actively leveraging this evolving framework. Operating at the intersection of oncology therapeutics and AI-driven drug development, Oncotelic demonstrates how scientific advancement can influence financial positioning. Through a diversified pipeline and strategic holdings, including a 45% interest in GMP Bio, which was recently assessed at more than $1 billion in enterprise value, the company illustrates how innovation can be reflected in tangible economic terms. As the industry increasingly aligns valuation with development progress rather than current revenue, Oncotelic represents a compelling example of science emerging as a recognized asset class. The company is part of a broader group of organizations developing advanced therapies at the genetic and molecular level, including Autolus Therapeutics plc (NASDAQ: AUTL), Wave Life Sciences Ltd. (NASDAQ: WVE), IO Biotech Inc. (NASDAQ: IOBTQ) and…

Olenox Industries (NASDAQ: OLOX) announced it received a delinquency notice from Nasdaq on April 21, 2026, for failing to file its Form 10-K for the year ended Dec. 31, 2025. The company has 60 days, until June 22, 2026, to submit a plan to regain compliance or file the report, with the potential for an extension of up to 180 days, through Oct. 13, 2026, if Nasdaq accepts its plan, as it works to address the deficiency and maintain listing compliance.

SEGG Media (NASDAQ: SEGG, LTRYW) highlighted strong engagement from its subsidiary Quadrant following the April 9 release of a YouTube video featuring Formula 1 drivers Lando Norris and Carlos Sainz Jr., which has generated more than four million views, including one million within the first 24 hours. The campaign, celebrating 100 years of karting, also drove more than 18.5 million social media impressions and 1.92 million engagements, reinforcing Quadrant’s growth strategy focused on premium content, talent-led storytelling, and expanding brand partnerships.

Solowin Holdings (NASDAQ: AXG) reported preliminary, unaudited results for the fiscal year ended March 31, 2026, highlighting revenue growth to between $27 million and $29 million, nearly ten times higher year over year, driven by expansion in digital asset tokenization, stablecoin infrastructure, and AI-powered services. The company reported a net loss of $11 million to $13 million amid continued investment in technology and global expansion, while cash and cash equivalents rose to between $14 million and $16 million, supported by $18 million to $20 million in financing inflows, as it advances its strategy centered on compliant, institutional-grade digital financial infrastructure.

This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising.